Volpara Health Technologies (ASX: VHT) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Volpara Health Technologies Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Volpara Health Technologies (ASX: VHT)
Latest News
Healthcare Shares
Morgans says these small cap ASX healthcare shares are buys with 50% upside
Opinions
I'd invest $10,000 into these excellent ASX shares for the long-term
Opinions
Why I think these ASX All Ords shares are extremely cheap right now
Growth Shares
Why I think it's a great time to start buying ASX growth shares
Small Cap Shares
Brokers say these small cap ASX shares are buys with huge upside potential
Small Cap Shares
Brokers say these small cap ASX shares are buys
Dividend Investing
How to make passive income for life with just $5 a day
Opinions
3 ASX All Ordinaries shares I'm watching like a hawk in March
Share Gainers
Why Arafura, Myer, Volpara, and Xero shares are zooming higher
Opinions
Sitting on cash? These 2 ASX shares are great buys today but won't be forever
Small Cap Shares
I'd aim for $1 million buying just a few ASX shares
Earnings Results
This All Ords share is booming 9% after turning cash flow positive
Frequently Asked Questions
-
No, the ASX healthcare share has not yet paid any dividends.
-
Volpara listed on 27 April 2016.
VHT ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Volpara Health Technologies
Volpara Health Technologies Ltd (ASX: VHT) is a small but growing research, development, and manufacturing company that provides breast screening technology and risk analysis for patients and medical professionals.
Volpara’s artificial intelligence-powered software for early detection of breast cancer is used by more than 2,000 facilities and more than 5,600 mammography technologists, impacting nearly 15 million patients globally. Volpara is based in Wellington, New Zealand, and also has a US office in Seattle.
Volpara Health Technologies Ltd (ASX: VHT) was removed from the ASX Official List on 22 May 2024.